Intraoperative iatrogenic type A aortic dissection is a rare but known complication of cardiac surgery, with an incidence of 0.06% to 0.23%. Results are frequently catastrophic. The endovascular approach has made advances as an alternative treatment for aortic disease. However, the apical approach for transcatheter thoracic endovascular aortic repair is not well known. We present a 5-year follow-up of a case of iatrogenic type A aortic dissection after minimally invasive mitral valve repair successfully resolved by medical stabilization and subsequent transapical thoracic endovascular aortic repair. (J Vasc Surg Cases and Innovative Techniques 2018;4:257-61.) Keywords: Aortic dissection; Endograft; Transapical Intraoperative iatrogenic aortic dissection is a rare but potentially catastrophic complication of open heart surgery, occurring in 0.06% of cardiac operations and resulting in 48% operative mortality.
Intraoperative iatrogenic aortic dissection is a rare but potentially catastrophic complication of open heart surgery, occurring in 0.06% of cardiac operations and resulting in 48% operative mortality. 1, 2 Any aortic or peripheral vessel manipulation during cardiac surgery could be a source of dissection, including femoral cannulation, cross-clamps, proximal anastomotic sites, and even intra-aortic balloon pumps. The endovascular approach has made advances as an alternative treatment for aortic disease. The apex of the left ventricle (LV) has gained popularity for introduction during transcatheter aortic valve implantation for overcoming limitations of the conventional femoral approach and supra-aortic approach, either a carotid or axillary artery. [3] [4] [5] [6] However, the apical approach for transcatheter thoracic endovascular aortic repair (TEVAR) is not well known. The patient consented to publication of this report. (Fig 2, F) . The left thoracotomy was closed with good hemostasis. To provide blood flow from the true lumen to the LRA, a 6-Â 14-mm Express (Boston Scientific, Marlborough, Mass) stent was deployed in the origin of the LRA (Fig 2, G) . The inferior mesenteric artery (IMA) was occluded using 6-Â 2-mm Tornado (Cook Medical, Bloomington, Ind) embolization coils to prevent retrograde blood flow into a false lumen and to attempt to completely cure it. Two 8-Â 38-mm Atrium covered stents (Maquet, Rastatt, Germany) were sequentially deployed into the abdominal aorta (AA ; Fig 2, H) . After repeated angiography of the AA, the right groin was closed with a percutaneous closure device. There was no evidence of immediate complications. Three days later, postprocedure CT demonstrated two successfully placed stents within the ascending TA with exclusion of the type A dissection and thrombosis of the intrathoracic false lumen (Fig 3) . There was persistent opacification of the false lumen from just above the level of the celiac artery to the LCIA, although it was significantly decreased in comparison to pre-TEVAR examination. CT also demonstrated a thrombosed IMA and a widely patent stent from the true lumen to the LRA. She was discharged after a 1-week hospital course.
CASE REPORT
One year later, CT showed no evidence of residual dissection and status post placement of stent graft devices in the AA with obliteration of the previously opacified false lumen without endoleak (Fig 4) . Involvement of the LCIA was no longer seen, the LRA stent was patent, and the IMA remained occluded status post coil embolization. The last follow-up CT scan, 4 years postoperatively, also showed full resolution of the dissection without complication. She had good performance without related symptoms at her most recent outpatient visit in February 2018.
DISCUSSION
Manipulation and cross-clamping of the ascending aorta with antegrade cardioplegia might be implicated in this case. When localized dissection of the ascending aorta was found on intraoperative TEE, the risk of sequential surgical treatment was considered along with the risk of iatrogenic type A aortic dissection. For conventional surgical treatment of this complication, the possibility of superimposed dissection, difficulty in obtaining alternative access for cardiopulmonary bypass, and, similarly, difficulties with cerebral and myocardial protection related to either dissectioninduced malperfusion or the unplanned need for alteration in cannulation site necessitated by the dissection should be considered. Because hemodynamic status was stable during the operation and the intraoperative TEE showed a localized flap, conservative management was decided. Although the aortic dissection progressed from the ascending aorta to involve the LCIA, IMA, and LRA, she nonetheless remained stable. We had ample time for discussion with the cardiothoracic team and the patient's family. Extensive strategic planning of the procedure was also possible. Although most pathologic processes involving the ascending aorta or aortic arch are considered unamenable to current endovascular treatment, she had excessively high risk for open repair because of recent heart surgery and manipulation of the aorta. Importantly, it was thought that transapical access would offer a more direct, anatomically favorable approach to the ascending aorta with the small caliber of the iliofemoral arteries (5 to 6 mm), the tortuosity of the aorta, and the bulky devices commercially available in 2011.
The apex of the LV is the "front door" to the arterial vascular system and as such has gained popularity in thoracic endovascular aortic valve repair. [3] [4] [5] [6] However, TaTEVAR is not well known. Although no access issues have been described so far during TaTEVAR, complications related to the transapical thoracic endovascular aortic valve repair remain a concern, including bleeding from the LV apex, formation of an LV apex pseudoaneurysm, and development of a late ventricular septal defect. [7] [8] [9] Our patient had no related symptoms and no evidence of complications on immediate CT, and a follow-up CT scan 4 years later showed full resolution of the dissection. The long-term follow-up in this case of TaTEVAR for iatrogenic aortic dissection is highly unique and valuable. 
